Skip to main content

Table 5 Correlation between serum p53Abs and clinicopathologic features

From: Prognostic role of serum p53 antibodies in lung cancer

  No. of cases No. of p53Ab-positive
Age (years)   
≤60 47 11 (23.4%)
>60 154 30 (19.5%)
Sex   
Male 157 29 (18.5%)
Female 44 12 (27.3%)
Histological type   
NSCLC   
Adenocarcinoma 79 10 (12.7%)
Squamous cell carcinoma 70 18 (25.7%)
Bronchioloalveolar carcinoma 6 0 (0%)
Large cell carcinoma 5 1 (20.0%)
Anaplastic carcinoma 19 5 (26.3%)
Mixed carcinoma 9 2 (22.2%)
SCLC 13 5 (38.5%)
NSCLC stage   
I 68 7 (10.3%)
II 24 7 (29.2%)
III 40 9 (22.5%)
IV 45 9 (20.0%)
Missing 11 4 (36.4%)
Total 188 36 (19.1%)
II-IV 109 25 (22.9%)
NSCLC grade   
G1 4 0 (0%)
G2 57 4 (7.0%)
G3 72 18 (25.0%)
Missing 55 14 (25.5%)
Total 188 36 (19.1%)